Objective: This research aims to determine the correlation between maternal age during pregnancy, low birth weight (LBW), prematurity, and history of hormonal drugs used in the first trimester of pregnancy with the occurrence of hypospadias. Material & Methods: This research is an observational analytic research with case control design. The sample in this study were 50 samples that consisting of 25 patients with hypospadias and 25 patients without hypospadias at Bina Sehat Jember Hospital, Paru Jember Hospital, and Bhayangkara Bondowoso Hospital. After determined every case and control group, data acquired retrospectively by traced the hypospadias risk factors (maternal age at pregnancy, LBW, prematurity, and history of hormonal drugs using in the first trimester of pregnancy) by interviewing the patient's mother. The data of this research were analyzed by bivariate and multivariate using SPSS 16.0. Bivariate analysis in this study used chi-square Yates correction (chi-square with continuity correction) and fisher's exact test, whereas multivariate analysis used logistic regression techniques with significance p-value<0.05. Results: The result of bivariate analysis in this study showed that variable maternal age during pregnancy more than 35 years (p = 0.667) has no correlation with occurrence of hypospadias, while variable of LBW (p = 0.027), prematurity (p = 0.041), and the history of hormonal drug use in the first trimester of pregnancy (p = 0.049) have a correlation with the occurrence of hypospadias. Conclusion: In this study, there was a significant correlation between LBW, prematurity, and history of hormonal drugs using in the first trimester of pregnancy with the occurrence of hypospadias. This study did not show a significant correlation between maternal age during pregnancy with the occurrence of hypospadias.
Hypospadias, Maternal Age, LBW, Prematurity, Hormonal Drugs
Sjamsuhidajat R, W Karnadihardja, TOH Prasetyono, dan R Budiman. Buku ajar ilmu bedah Sjamsuhidajat-de Jong. Edisi tiga. Jakarta: EGC. 2010.
Brouwers MM, WFJ Feitz, LAJ Roelofs, LALM Kiemeney, RPE de Gier, and N Roeleveld. Risk factors for hypospadias. Eur J Pediatr. 2007; 166: 671-678.
Zanden LFVD, IAV Rooij, WF Feitz, B Franke, NV Knoers, and N Roeleveld. Aetiology of hypospadias: a systematic review of genes and environment. Hum Reprod Update. 2012; 18: 260–283.
Xu L, C Liang, J Lipianskaya, X Chen, S Fan, L Zhang, et al. Risk factors for hypospadias in China. Asian Journal of Andrology. 2014; 16: 778-781.
Mohammadzadeh A, A Farhat, H Esmaieli, and S Shiranzaei. Prevalence and risk Factors of hypospadias in a private hospital in Northeast Iran. Iran J Pediatr. 2011; 21(4): 497-501.
Akin Y, O Ercan, B Telatar, F Tarhan, and S Comert. Hypospadias in Istanbul: incidence and risk factors. Pediatrics International. 2011; 53: 754-760.
Kalfa N, F Paris, MO Soyer-Gobillard, JP Daures, and C Sultan. Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study. Fertil Steril. 2011; 95: 2574–2577.
Rooij IAV, LFM Van der Zanden, MM Brouwers, NV Knoers, WF Feitz, and N Roeleveld. Risk factors for different phenotypes of hypospadias: Results from a Dutch case control study. BJU International. 2013; 112: 121-128.
Carmichael SL, GM Shaw, C Laurent, MS Croughan, RS Olney, EJ Lammer, and The National Birth Defects Prevention Study. Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med. 2005; 159: 957-962.
Tangkudung FJ, SY Patria, dan E Arguni. Faktor risiko hipospadia pada anak di RSUP Dr. Sardjito Yogyakarta. Sari Pediatri. 2016; 17(5): 396-400.
Butwicka A, P Lichtenstein, M Landen, AS Nordenvall, A Nordenstrom, A Nordenskjold, and L Frisen. Hypospadias and increased risk for neurodevelopmental disorders. Journal of Child Psychology and Psychiatry. 2014. p. 1-7.
Brouwers MM, LFMVD Zanden, RPED Gier, EJ Barten, GA Zielhuis, WFJ Feitz, and N Roeleveld. Hypospadias: risk factor patterns and different phenotypes. BJU International. 2009; 105: 254-262.
Carmichael SL, GM Shaw, and CJ Curry. Hypospadias in California: trends and descriptive epidemiology. Epidemiology. 2003; 14: 701-706.
Hsieh MH, DG Alonzo, ET Gonzales, EA Jones, LJ Cisek, and DR Roth. Ex-premature infant boys with hypospadias are similar in size to age matched, ex-premature infant boys without hypospadias. Journal of Pediatric Urology. 2011; 7: 543-547.
Klip H, J Verloop, JD van Gool, ME Koster, CW Burger, FE van Leeuwen, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet. 2002; 359: 1102-1107.
Sharpe RM. The “oestrogen hypothesis” – where do we stand now?. Int J Androl. 2003; 26: 2–15.
Dean HJ and JS Winter. The effect of five synthetic progestational compounds on 5-alpha-reductase activity in genital skin fibroblast monolayers. Steroids. 1984; 43(1): 13-17.
Kallen B. Epidemiology of Human Congenital Malformations. Switzerland: Springer International Publishing. 2014. p. 95-98.
Hsieh MH, BN Breyer, ML Eisenberg, and LS Baskin. Associations among hypospadias, cryptorchidism, anogenital distance, and endocrine disruption. Curr Urol Rep. 2008; 9: 137-142.
George M, FJ Schneuer, SE Jamieson, and AJA Holland. Genetic and environmental factors in the aetiology of hypospadias. Pediatr Surg Int. 2015; 31: 519-527.